NCT04946318 - Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma | Biotech Hunter

Enrollment

136

Participants

Timeline

Start Date

September 8, 2021

Primary Completion Date

September 8, 2022

Study Completion Date

September 8, 2022

Conditions

Asthma

Interventions

DRUG

CSJ117

CSJ117 (0.5 mg, 1mg, 2mg, 4 mg and 8 mg) capsules for inhalation once daily delivered via Concept1 inhalation device for 12 or 24 weeks.

DRUG

Placebo

Placebo inhaled once daily for 12 or 24 weeks. Delivered via Concept1 device.

Trial Locations (58)

1003

Novartis Investigative Site, Manila

1038

Novartis Investigative Site, Riga

1884

Novartis Investigative Site, Ranelagh, Partido de Berazate

2100

Novartis Investigative Site, Gödöllő

2660

Novartis Investigative Site, Balassagyarmat

2900

Novartis Investigative Site, Komárom

3100

Novartis Investigative Site, Paraná

4000

Novartis Investigative Site, San Miguel de Tucumán

5000

Novartis Investigative Site, Iloilo City

5100

Novartis Investigative Site, Erpent

5500

Novartis Investigative Site, Mendoza

6000

Novartis Investigative Site, Stara Zagora

7002

Novartis Investigative Site, Rousse

10119

Novartis Investigative Site, Berlin

10717

Novartis Investigative Site, Berlin

10969

Novartis Investigative Site, Berlin

12159

Novartis Investigative Site, Berlin

21162

Novartis Investigative Site, White Marsh

29607

Novartis Investigative Site, Greenville

30033

Novartis Investigative Site, Krakow

30060

Novartis Investigative Site, Marietta

41002

Novartis Investigative Site, Lovosice

58452

Novartis Investigative Site, Witten

60596

Novartis Investigative Site, Frankfurt

73120

Novartis Investigative Site, Oklahoma City

75069

Novartis Investigative Site, McKinney

78006

Novartis Investigative Site, Boerne

90017

Novartis Investigative Site, Los Angeles

90025

Novartis Investigative Site, Los Angeles

92647

Novartis Investigative Site, Huntington Beach

93301

Novartis Investigative Site, Bakersfield

93401

Novartis Investigative Site, Levice

194354

Novartis Investigative Site, Saint Petersburg

410012

Novartis Investigative Site, Saratov

C1122AAK

Novartis Investigative Site, CABA

S2000JKR

Novartis Investigative Site, Rosario

L7N 3V2

Novartis Investigative Site, Burlington

M9V 4B4

Novartis Investigative Site, Etobicoke

H2V 2K1

Novartis Investigative Site, Montreal

415 01

Novartis Investigative Site, Teplice

D-04299

Novartis Investigative Site, Leipzig

D-04347

Novartis Investigative Site, Leipzig

223-0059

Novartis Investigative Site, Yokohama

530 0001

Novartis Investigative Site, Osaka

104-0031

Novartis Investigative Site, Chuo Ku

103-0003

Novartis Investigative Site, Chuo-ku

103-0028

Novartis Investigative Site, Chuo-ku

187-0024

Novartis Investigative Site, Kodaira

157-0072

Novartis Investigative Site, Setagaya-Ku

158-0097

Novartis Investigative Site, Setagaya-ku

170-0003

Novartis Investigative Site, Toshima City

170 0003

Novartis Investigative Site, Toshima Ku

531-0073

Novartis Investigative Site, Osaka

551-0032

Novartis Investigative Site, Osaka

LV-5417

Novartis Investigative Site, Daugavpils

LV 1002

Novartis Investigative Site, Riga

60-693

Novartis Investigative Site, Poznan

60-823

Novartis Investigative Site, Poznan